BRIEF published on 12/04/2025 at 17:50, 12 hours 8 minutes ago The Rise of Cytofast Auto: A New Era in Cytology Financial Impact Global Healthcare Market Dynamics Automation Technology Cytology Innovation
PRESS RELEASE published on 12/04/2025 at 17:45, 12 hours 13 minutes ago Inside Information / Other news releases Hospitex International announces Cytofast Auto, the first fully automatic and universal LBC processor, a game changer in the cytology sector, revolutionizing workflows and market dynamics Automation Market Dynamics Cytofast Auto Universal LBC Processor Cytology Sector
BRIEF published on 11/24/2025 at 18:41, 10 days 11 hours ago Hospitex Pioneers Oncology Diagnostic Projects in Asia Hospitex Asian Markets Oncology Diagnostics International Projects Urine24
PRESS RELEASE published on 11/24/2025 at 18:36, 10 days 11 hours ago Inside Information / Other news releases Hospitex prepares Urine24 pilot project in Far East after ADB visit. Launching oncology diagnostics pilot projects in collaboration with Asian countries. Hospitex advances technology-driven cancer diagnostics internationally Pilot Project Hospitex Oncology Diagnostics Urine24 ADB Visit
BRIEF published on 06/04/2025 at 07:35, 6 months ago ALIKO SCIENTIFIC Signs Exclusive Distribution Agreement with Menarini Diagnostics Oncology Diagnostics FISH Technology ALIKO SCIENTIFIC Menarini Diagnostics Italy Distribution
PRESS RELEASE published on 06/04/2025 at 07:30, 6 months ago Inside Information / Other news releases ALIKO SCIENTIFIC's Italian subsidiary Hospitex signs exclusive distribution agreement with Menarini Diagnostics, enhancing pathology solutions in the market Hospitex ALIKO SCIENTIFIC Menarini Diagnostics Exclusive Distribution Pathology Solutions
BRIEF published on 05/30/2025 at 17:50, 6 months 5 days ago Ikonisys postpones the publication of its annual financial report again Financial Report Consolidation Hospitex Delayed Publication Ikonisys
BRIEF published on 04/25/2025 at 17:50, 7 months 9 days ago Ikonisys Delays 2024 Annual Financial Report Financial Report Cancer Diagnostics Ikonisys Hospitex Integration 2024 Results
PRESS RELEASE published on 04/25/2025 at 17:45, 7 months 9 days ago Inside Information / Other news releases ALIKO SCIENTIFIC (Ikonisys SA) postpones the 2024 annual financial report publication to integrate Hospitex International's accounts for the first time, ensuring thorough consolidation and transparency Financial Report Consolidation Postponement Hospitex International ALIKO SCIENTIFIC
BRIEF published on 02/27/2025 at 19:22, 9 months 5 days ago Ikonisys Finalizes €500k Private Capital Increase Private Placement Global Expansion Capital Increase Oncology Diagnostics Shareholder Expansion
Published on 12/05/2025 at 02:35, 3 hours 23 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 58 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 53 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 58 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 27 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 7 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 32 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 43 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 47 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 58 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 13 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 14 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 57 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
